Frequently Asked Questions About Healthcare AI Governance

Generic GRC platforms are built to manage policies, tasks, and third-party risk. Onboard AI is purpose-built for healthcare AI governance. It provides a structured AI risk evaluation pipeline — including intake and triage, assessment automation, healthcare-specific testing using FHIR standards, and a longitudinal Canonical Product Profile that captures lifecycle oversight.
Onboard AI does not replace GRC. It operationalizes AI governance within healthcare.

No. Onboard AI can ingest tickets from existing enterprise systems, running a parallel workflow for deep, healthcare-specific AI risk evaluation, then can send the package back to your existing enterprise management tool. While Onboard AI offers a robust workflow web application, it can also be utilized purely via APIs.

Assessments align with recognized healthcare risk frameworks such as CHAI, NIST, WHO, Join Commission, etc. and relevant state and federal regulatory requirements. 

Additionally, AI testing and monitoring is uniquely built for healthcare, leveraging FHIR APIs and data, plus recognized healthcare evaluation benchmarks.

By enforcing consistent requirements in the form of controls, evidence, ownership and mitigations, AI tools under evaluation are quickly identified according to their risk profiles. This allows AI implementers to make faster, more informed decisions based on standardized heuristics. The result is fewer stalled pilots, less work and clearer accountability.

AI intake involves collecting structured information about intended use, risk profile, technical details, and operational impact. A standardized intake process helps determine whether a tool requires full assessment or streamlined documentation.

Risk-based triage routes AI tools through different levels of scrutiny based on their clinical, operational, or financial impact. Lower-risk tools require proportionate review, while higher-risk tools receive deeper multidisciplinary evaluation.

Evaluation frameworks such as CHAI, NIST, and Joint Commission guidance are used to structure assessments. Reviews align AI tools with recognized healthcare standards and document how criteria were met.

Healthcare AI governance committees bring together clinical, IT, legal, operational, and executive stakeholders. They review structured documentation and determine whether deployment conditions and mitigations are appropriate.

Structured intake, standardized documentation requirements, and centralized review records reduce ad hoc data requests and repetitive meetings. This improves efficiency while preserving rigor.

Governance workflows can be structured to reflect recognized standards such as CHAI and NIST AI Risk Management Framework principles. Evaluations document alignment and identify mitigation requirements where gaps exist.

Audit-ready documentation typically includes intake records, risk assessments, mitigation plans, deployment conditions, monitoring triggers, and reassessment history. A structured system of record simplifies retrieval.

Mitigation plans are documented alongside assigned ownership and follow-up requirements. Monitoring triggers and reassessment checkpoints ensure safeguards remain active and appropriate.

Structured governance reduces exposure by ensuring risks are identified, mitigated, and documented before deployment. While no system eliminates risk, disciplined oversight strengthens defensibility.

Regulatory updates may require reassessment of existing tools. A lifecycle-based governance system allows organizations to identify impacted tools and document updated oversight actions.

Post-deployment governance includes monitoring performance, tracking adherence to deployment conditions, and triggering reassessment when risk profiles change.

Version releases or functionality changes can prompt structured reassessment. Governance records are updated to reflect new risk evaluations and mitigation requirements.

Ongoing monitoring involves tracking risk indicators, autonomy changes, data shifts, and operational impact. Monitoring ensures AI systems continue to meet clinical and regulatory expectations.

Deployment conditions and intended use parameters are documented within the governance record. Reassessment processes help prevent uncontrolled expansion of scope.

Yes. Monitoring cadence and oversight intensity can be aligned to risk level and use case, allowing proportionate governance without unnecessary burden.

No. AI governance complements existing GRC and ITRM systems. It provides structured oversight specific to AI tools while integrating with enterprise risk infrastructure.

By centralizing documentation and evaluation history, all stakeholders operate from the same structured record. This reduces fragmentation across departments.

Yes. Organizations can formalize AI governance in phases, starting with intake standardization and expanding to full lifecycle oversight over time.

A centralized system of record allows standardized workflows across facilities while supporting configurable controls based on risk, use case, or local requirements.

Executive leaders set governance standards, ensure accountability, and oversee risk alignment. Structured infrastructure enables visibility without requiring constant direct involvement.

Intended use, patient population, workflow impact, and safety considerations are documented during intake and assessment. Clinical expertise is embedded in structured review.

Operational feasibility, system integration impact, and workflow changes are reviewed alongside clinical and regulatory factors to ensure responsible deployment.

Defined deployment conditions, monitoring triggers, and reassessment processes ensure AI tools operate within documented safeguards.

Monitoring triggers can prompt reassessment and mitigation updates. Governance records are updated to reflect new findings.

Each AI tool maintains a longitudinal profile documenting evaluation, mitigations, and oversight history. This record persists beyond individual leaders or committees.